https://insights.hoganlovells.com/report/adlegallearningcenter/ 2026-04-30T11:46:51Z https://insights.hoganlovells.com/report/adlegallearningcenter/innovation-series 2026-04-30T11:46:51Z https://insights.hoganlovells.com/report/adlegallearningcenter/regulatory 2026-04-30T11:46:51Z https://insights.hoganlovells.com/report/adlegallearningcenter/corporate 2026-04-30T11:46:51Z https://insights.hoganlovells.com/report/adlegallearningcenter/international-trade-and-economic-regulation 2026-04-30T11:46:51Z https://insights.hoganlovells.com/report/adlegallearningcenter/disputes-and-investigations 2026-04-30T11:46:51Z https://insights.hoganlovells.com/report/adlegallearningcenter/privacy-and-information-management 2026-04-30T11:46:51Z https://insights.hoganlovells.com/report/adlegallearningcenter/space 2026-04-30T11:46:51Z https://insights.hoganlovells.com/report/adlegallearningcenter/intellectual-property 2026-04-30T11:46:51Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/ 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/contents 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/aerospace-and-defense 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/automotive-and-mobility 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/consumer 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/education 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/energy 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/financial-institutions 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/insurance 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/life-sciences-and-health-care 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/manufacturing-and-industrials 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/private-capital 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/real-estate 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/sports-media-and-entertainment 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/technology 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/transportation-and-logistics 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/growth-equity-and-venture-capital 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/private-equity 2026-04-21T06:13:28Z https://insights.hoganlovells.com/report/ma-year-in-review-2025/new-corporate-finance-partners-and-counsel 2026-04-21T06:13:28Z https://insights.hoganlovells.com/events/housing-works-distribution-center/ 2026-04-28T07:47:51Z https://insights.hoganlovells.com/report/inta-2026-ip-resources/ 2026-05-06T06:36:18Z https://insights.hoganlovells.com/report/medtech-forum-2026/ 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/ai-pharmaceutical-applications-and-the-uk-regulatory-response 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-ai-act-and-mdr-regulate-ai-enabled-devices 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-ai-act-exemptions-for-medical-devices-a-disruptive-shift-in-regulatory-scope 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/litigation-readiness-strategies-for-evolving-ai-product-liability-rules 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/how-fda-itself-is-using-ai-and-what-it-means-for-drugs-devices-and-biologics 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/wellness-product-or-device-understanding-fdas-expectations-for-consumer-and-aesthetic-products 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/inside-mexicos-landmark-2026-digital-health-amendment 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/insuring-ai-risks-is-your-business-already-covered 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/data-privacy-and-cybersecurity 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/fdas-evolving-cybersecurity-expectations-for-aiml-submissions 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/online-tracking-technology-litigation-risks-evolve-for-health-care-organizations 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-data-act-data-license-requirements-for-connected-devices-and-health-wearables 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-digital-omnibus-and-data-act-implications-for-trade-secret-protection 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/beyond-the-banner-cookie-consent-expectations 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/how-to-ensure-compliance-with-the-european-health-data-space-regulation 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/ai-and-federated-learning-privacy-enhancing-technology-for-ai-drug-development 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/a-practical-data-privacy-guide-on-frances-methodologies-of-reference 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/data-migration-and-regulatory-dossier-transfer-information-as-a-core-asset-in-ma 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/ethical-and-legal-challenges-presented-by-ai-in-health-care 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/manufacturing-and-supply-chain 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/future-of-manufacturing-in-life-sciences-and-health-care 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/energy-concerns-shaping-the-future-of-life-sciences-and-health-care 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-companies-operationalizing-supply-chain-due-diligence-in-2026 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/manufacturing-reshoring-momentum-fda-precheck-and-the-future-of-us-drug-manufacturing 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/dscsa-supply-chain-rules-in-2026-and-how-upstream-partners-can-de-risk 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/ai-supply-chain-management-for-devices-technical-imperatives-for-the-qmsr-era 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/qmsr-becomes-mandatory-implementation-at-the-intersection-of-quality-and-legal-risk 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/negotiating-frame-supply-agreements-more-legal-certainty-in-germany 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-regulatory-initiatives-to-tackle-medicine-shortages 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/shortages-and-accountability-what-the-law-can-and-cannot-fix 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/cjeu-mulls-questions-over-pharmacy-compounding-restrictions 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-green-claims-under-scrutiny-compliance-priorities-for-companies-under-the-empco-directive 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/assessing-frances-health-care-reform-on-nuclear-medicine 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/preparing-for-the-worst-case-scenario-what-war-could-mean-for-manufacturers 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/geopolitical-and-regulatory-changes 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/most-favored-nation-drug-pricing-models-make-global-waves-in-2026 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/implications-of-the-most-favored-nation-policy-for-the-eu-pharmaceuticals-market 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/tariff-enforcement-meets-the-fca-liability-under-the-trump-administrations-tariff-regime 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/increased-use-of-cmmi-authority-to-change-us-medicare-payment-policy 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/net-price-and-confidentiality-a-key-challenge-in-the-pharmaceutical-industry 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/french-pharmaceutical-market-access-amid-budgetary-strain-and-cost-containment 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/fda-targets-direct-to-consumer-prescription-drug-advertising 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/dtc-balancing-act-set-to-continue-for-pharmaceutical-industry-in-2026 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-liability-landscape-shifts-as-ai-enabled-devices-face-diverging-mdr-pld-rules 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/biosecure-act-enacted-to-restrict-us-transactions-with-companies-of-concern 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/us-country-of-origin-compliance-navigating-an-evolving-enforcement-landscape 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/renewed-focus-on-bayh-dole-and-federally-funded-inventions 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/the-hospital-as-a-global-institution 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/ma-licensing-and-commercial-transactions 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/key-legal-issues-shaping-life-sciences-and-health-care-ma 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/efforts-obligations-looking-beyond-the-definition-in-life-sciences-collaborations 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/the-benefits-of-arbitrating-life-sciences-disputes 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/new-ma-playbook-for-aienabled-devices 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/navigating-contractual-issues-arising-from-clinical-trials 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/standard-contractual-clauses-for-clinical-trial-agreements-in-germany-what-sponsors-need-to-know 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/cross-border-licensing-to-acquire-structures-a-new-page-in-the-ma-playbook-in-a-constrained-deal-market 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/regulatory-risk-arbitrage-ma-navigating-transactions-amid-divergent-regulatory-requirements 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/financialization-of-private-practice-companies-in-france-effective-control-as-a-governance-standard 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/the-rise-of-newco-models-in-china-legal-structures-for-cross-border-pharma-partnerships 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/chinas-drug-regulatory-data-protection-rules-implications-for-licensing-transactions 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/japan-2026-life-sciences-transactions-shift-from-caution-to-catalyst 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/clinical-trials 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/fda-clinical-trials-in-2026-technology-enabled-patient-centered-inspection-ready 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/from-pilot-to-practice-fdas-evolving-use-of-real-world-evidence 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/licensing-implications-of-ai-use-in-medical-products 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/fda-bimo-inspection-trends-key-takeaways-and-practical-guidance-for-sponsors 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/an-overview-of-the-new-eu-biotech-act 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-biotech-act-implications-for-clinical-trial-sponsors 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/data-protection-in-clinical-trials-under-the-eu-biotech-act-a-shift-toward-greater-harmonization 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/fast-track-authorization-pathways-for-clinical-trials-the-european-initiative-and-national-implementations 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/uk-clinical-trials-regulatory-reform-fuels-new-era-of-growth-and-global-ambition 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/harmonizing-data-protection-practices-under-germanys-new-standard-contractual-clauses-for-ctas 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/trial-diversity-in-the-eu-women-and-pregnant-or-lactating-women 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/decentralized-clinical-trials-in-france-identifying-barriers-to-progress 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/congress-fda-advance-policies-to-phase-out-animal-testing 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/ldts-ivds-ruos-reagents-collection-kits-and-analytical-software-where-fda-is-drawing-the-lines 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/fda-signals-long-awaited-embrace-of-bayesian-methods-in-drug-and-biologic-trials 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/ctgts-and-rare-disease-therapies 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/determining-sameness-of-cellular-and-gene-therapy-products-for-exclusivity-and-other-regulatory-purposes 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/evolving-cybersecurity-risk-landscape-for-cell-tissue-and-gene-therapy-companies 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/the-unified-patent-court-is-a-key-forum-for-disputes-concerning-advanced-therapy-patents 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/ctgts-face-increased-competition-by-hospital-exemption-in-europe 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/fda-breaks-new-ground-for-rare-disease-approval-pathways 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/fdas-fast-evolving-biosimilar-and-interchangeability-frameworks 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/fda-breakthrough-devices-program-driven-by-reimbursement-benefits 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/advancing-access-to-orphan-drugs-in-latin-america 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/antitrust-competition-and-economic-regulation 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/merger-control-fdi-and-fsr-filing-considerations-for-life-sciences-transactions 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/blockbusters-and-market-power-patent-playbooks-under-scrutiny 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/legal-scrutiny-rising-for-algorithmic-pricing-in-health-care 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/below-threshold-scrutiny-in-eu-life-sciences-deals 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/zero-price-and-complimentary-commercial-models-in-italy-regulatory-and-competition-considerations 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-antitrust-compliance-in-market-access-for-combination-therapies 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/antitrust-dawn-raids-in-the-eu-dynamics-dos-and-donts-for-life-sciences-companies 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-antitrust-compliance-in-purely-contractual-global-strategic-pharmaceutical-alliances 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/global-compliance-and-litigation 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/a-whole-new-world-a-global-view-on-anti-corruption-priorities 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/recalls-private-enforcement-and-rising-liability-pld-reshaping-eu-life-sciences-risks 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-member-states-implement-product-liability-directive-snapshots-for-france-germany-italy-and-spain 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/the-role-of-ce-marking-and-marketing-authorizations-in-upc-case-law-a-springboard-to-long-arm-jurisdiction 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/upc-litigation-clarifying-when-preliminary-injunctions-may-be-granted 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/important-class-action-rulings-in-life-sciences-2025-and-what-lies-ahead 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/new-german-arbitration-solutions-for-third-party-involvement-minimize-risk-and-complexity 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/uk-provider-selection-regime-trends-in-panel-decisions 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/policy-meets-enforcement-how-the-trump-administration-is-leveraging-the-false-claims-act-on-gender-affirming-care 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/the-new-lobbying-landscape-implications-for-life-sciences-in-europe 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eurasian-pharma-registry-patent-enforcement-benefits-for-the-pharmaceutical-industry 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/managing-risks-from-compulsory-licenses-based-on-patent-non-use-in-the-eurasian-economic-union 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/doing-business-in-the-eu 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/key-european-product-launch-considerations-for-pharmaceuticals-biotechnology-and-device-companies 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/life-sciences-patents-before-the-unified-patent-court 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/using-influencer-marketing-to-promote-health-care-products-and-services-in-the-eu 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/pharmacy-compounding-in-competition-to-a-manufacturer-proprietary-drug-product 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/commercial-launch-and-reimbursement-assessment-in-the-eu-gene-tests-and-ldts 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-pharma-law-package-regulatory-data-exclusivity 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/value-based-pricing-and-market-authorization-in-the-eu-for-new-therapeutic-indications 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/eu-health-technology-assessment-lessons-learned-in-year-one 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/medical-cannabis-in-france-post-experimentation-uncertainty-in-2025 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/doing-business-in-apac 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/apacs-rapidly-evolving-patchwork-of-rules-governing-ai-in-health-care 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/china-persistent-compliance-risks-for-cros-in-clinical-trials-amid-strengthened-nmpa-oversight 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/chinas-digital-therapeutics-and-ai-in-health-care-where-does-regulation-begin 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/hgr-compliance-in-practice-how-foreign-companies-can-lawfully-conduct-joint-rd-in-china-without-breaching-genetic-data-rules 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/strategic-localization-navigating-chinas-new-medical-device-registration-framework 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/china-takes-a-major-step-toward-pharmaceutical-trial-data-protection 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/resolving-life-sciences-disputes-in-china-navigating-2025-arbitration-law-reform 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/japan-increasing-promotion-of-clinical-development-partnerships 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/inventorship-de-facto-patent-linkage-ai-and-frand-ip-strategy-paramount-in-japan 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/medtech-forum-2026/get-in-touch 2026-05-08T06:34:17Z https://insights.hoganlovells.com/report/ai-health-and-law-summit-thought-leadership-2026/ 2026-05-13T13:33:10Z https://insights.hoganlovells.com/events/paint-and-sip/ 2026-05-19T11:26:46Z https://insights.hoganlovells.com/report/senior-associates/ 2026-06-01T11:09:55Z https://insights.hoganlovells.com/2026-state-of-play/ 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/overview 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/the-united-states 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/the-united-kingdom-england-wales 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/france 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/germany 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/italy 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/spain 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/mexico 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/indonesia 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/the-netherlands 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/the-global-class-actions-2026-core-team 2026-05-14T06:58:34Z https://insights.hoganlovells.com/2026-state-of-play/about-hogan-lovells 2026-05-14T06:58:34Z